Blephamide (sulfacetamide recalls
The FDA has published 2 recalls involving Blephamide (sulfacetamide since 2015. The latest was reported on 5 Jul 2017. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 Jul 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why blephamide (sulfacetamide is recalled
Companies
By year
All blephamide (sulfacetamide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Blephamide (sulfacetamide sodium recalled by Allergan Sales | Allergan Sales | Potency & Assay | Nationwide |
| Drug | CLASS II | Blephamide (sulfacetamide sodium recalled by Allergan Sales | Allergan Sales | Particulate Matter | Nationwide |
Should you stop taking Blephamide (sulfacetamide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.